scispace - formally typeset
L

Lin Kang

Researcher at Jinan University

Publications -  5
Citations -  60

Lin Kang is an academic researcher from Jinan University. The author has contributed to research in topics: Inflammation & Cholestasis. The author has an hindex of 2, co-authored 5 publications receiving 23 citations.

Papers
More filters
Journal ArticleDOI

Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.

TL;DR: TEC treatment restored diabetes-induced glucose and lipid metabolic disorder; and improved the deterioration of renal function, particularly the renal endothelium function in db/db mice, suggesting that TEC have a potently effect for retarding type 2 diabetes-associated DN.
Journal ArticleDOI

miR-378 and its host gene Ppargc1β exhibit independent expression in mouse skeletal muscle.

TL;DR: The findings identify a regulatory model of miR-378 expression, thereby helping to understand its physiological function in skeletal muscle, and identify some intronic miRNAs that are processed from primary host gene transcripts and share the promoter of their host.
Journal ArticleDOI

Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.

TL;DR: In this article, a natural anthraquinone derivative extracted from rhubarb, danthron can activate AMPKα in vitro and PPARα in vivo, which significantly attenuated the obesity and associated metabolic associated fatty liver diseases by enhancing hepatic fatty acid oxidation, decreasing lipid synthesis, and promoting mitochondrial homeostasis.
Journal ArticleDOI

Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages

TL;DR: In this paper, Pterostilbene (PTE) is an activator of SIRT1, which is a promising target for the treatment of human cholestatic liver disease (CLD).